Literature DB >> 16635708

Intranasal midazolam therapy for pediatric status epilepticus.

Timothy R Wolfe1, Thomas C Macfarlane.   

Abstract

Prolonged seizure activity in a child is a frightening experience for families as well as care providers. Because duration of seizure activity impacts morbidity and mortality, effective methods for seizure control should be instituted as soon as possible, preferably at home. Unfortunately, parenteral methods of medication delivery are not available to most caregivers and rectal diazepam, the most commonly used home therapy, is expensive and often ineffective. This brief review article examines recent research suggesting that there is a better way to treat pediatric seizures in situations where no intravenous access is immediately available. Intranasal midazolam, which delivers antiepileptic medication directly to the blood and cerebrospinal fluid via the nasal mucosa, is safe, inexpensive, easy to learn by parents and paramedics, and provides better seizure control than rectal diazepam.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16635708     DOI: 10.1016/j.ajem.2005.11.004

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage.

Authors:  Shyamoshree Basu; Amal Kumar Bandyopadhyay
Journal:  AAPS PharmSciTech       Date:  2010-08-04       Impact factor: 3.246

2.  A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease.

Authors:  Janet Hardy; Clare Randall; Eve Pinkerton; Christopher Flatley; Kristen Gibbons; Simon Allan
Journal:  Support Care Cancer       Date:  2016-02-18       Impact factor: 3.603

Review 3.  Intranasal delivery of antiepileptic medications for treatment of seizures.

Authors:  Daniel P Wermeling
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

4.  Intranasal midazolam compared with intravenous diazepam in patients suffering from acute seizure: a randomized clinical trial.

Authors:  Mohsen Javadzadeh; Kourosh Sheibani; Mozhgan Hashemieh; Hedyeh Saneifard
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

5.  Nasal and buccal treatment of midazolam in epileptic seizures in pediatrics.

Authors:  Ayşe Ulgey; Recep Aksu; Cihangir Bicer
Journal:  Clin Med Insights Pediatr       Date:  2012-07-24

Review 6.  Intranasal treatment of central nervous system dysfunction in humans.

Authors:  Colin D Chapman; William H Frey; Suzanne Craft; Lusine Danielyan; Manfred Hallschmid; Helgi B Schiöth; Christian Benedict
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.